Spots Global Cancer Trial Database for islet cell tumor
Every month we try and update this database with for islet cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | NCT02038738 | Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma | 68Ga-DOTATATE w... | 18 Years - | Ochsner Health System | |
| Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization | NCT00434109 | Neuroendocrine ... Islet Cell Tumo... | Sunitinib malat... Hepatic Artery ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors | NCT00602082 | Gastrointestina... Islet Cell Tumo... | capecitabine cisplatin streptozocin DNA analysis RNA analysis protein analysi... proteomic profi... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors | NCT02038738 | Neuroendocrine Neuroendocrine ... Neuroendocrine ... Neuroendocrine ... Carcinoid Carcinoid Tumor Islet Cell Tumo... Apudoma | 68Ga-DOTATATE w... | 18 Years - | Ochsner Health System | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
| Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery | NCT00416767 | Gastrointestina... Islet Cell Tumo... Neoplastic Synd... | fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | Federation Francophone de Cancerologie Digestive | |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors | NCT00227617 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... Neuroendocrine ... | bevacizumab 5-fluorouracil leucovorin oxaliplatin | 18 Years - | University of California, San Francisco | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00017199 | Gastrointestina... Islet Cell Tumo... | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET | NCT01374451 | Islet Cell Tumo... | Everolimus Pasireotide LAR | 18 Years - | Novartis | |
| Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors | NCT00466856 | Head and Neck C... Islet Cell Tumo... Metastatic Canc... Pheochromocytom... | octreotide acet... yttrium Y 90 re... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
| 68Ga-DOTATATE PET Scan in Neuroendocrine Cancer | NCT01396382 | Neuroendocrine ... | 68Ga-DOTATATE P... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery | NCT00416767 | Gastrointestina... Islet Cell Tumo... Neoplastic Synd... | fluorouracil irinotecan hydr... leucovorin calc... | 18 Years - 80 Years | Federation Francophone de Cancerologie Digestive | |
| AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors | NCT00427349 | Gastrointestina... Islet Cell Tumo... Neoplastic Synd... | AMG 706 octreotide | 18 Years - | Eastern Cooperative Oncology Group | |
| AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors | NCT00427349 | Gastrointestina... Islet Cell Tumo... Neoplastic Synd... | AMG 706 octreotide | 18 Years - | Eastern Cooperative Oncology Group | |
| PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00017199 | Gastrointestina... Islet Cell Tumo... | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | NCT00006368 | Brain and Centr... Breast Cancer Gastrointestina... Islet Cell Tumo... Lung Cancer Lymphoma Melanoma (Skin) Neoplastic Synd... | yttrium Y 90-ed... | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
